D. Goldstein

1.5k total citations
37 papers, 1.1k citations indexed

About

D. Goldstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, D. Goldstein has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in D. Goldstein's work include Radiopharmaceutical Chemistry and Applications (14 papers), Lymphoma Diagnosis and Treatment (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). D. Goldstein is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Lymphoma Diagnosis and Treatment (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). D. Goldstein collaborates with scholars based in United States, Australia and Canada. D. Goldstein's co-authors include Sally J. DeNardo, Gerald L. DeNardo, Sui Shen, Linda A. Kroger, Kathleen R. Lamborn, David L. Kukis, Cindy Lin, Sung Soo Park, Michael Friedländer and Arun V. Krishnan and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Neurology.

In The Last Decade

D. Goldstein

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Goldstein United States	19	458	402	339	266	108	37	1.1k
A. Bischof-Delaloye Switzerland	17	779 1.7×	544 1.4×	482 1.4×	299 1.1×	180 1.7×	41	1.6k
Syed M. Quadri United States	19	439 1.0×	189 0.5×	208 0.6×	195 0.7×	141 1.3×	79	993
Jun Hashimoto Japan	16	343 0.7×	377 0.9×	97 0.3×	154 0.6×	255 2.4×	65	1.4k
Bogdan Małkowski Poland	14	359 0.8×	131 0.3×	299 0.9×	225 0.8×	68 0.6×	71	782
Siew Wan Hee Singapore	18	106 0.2×	393 1.0×	316 0.9×	237 0.9×	112 1.0×	54	1.2k
Michela Donadio Italy	23	249 0.5×	1.1k 2.7×	253 0.7×	330 1.2×	352 3.3×	68	1.8k
Chris Plummer United Kingdom	16	179 0.4×	605 1.5×	93 0.3×	190 0.7×	170 1.6×	60	1.4k
Bang‐Bin Chen Taiwan	22	447 1.0×	346 0.9×	145 0.4×	245 0.9×	127 1.2×	69	1.4k
Piet L. Jager Netherlands	15	364 0.8×	256 0.6×	56 0.2×	281 1.1×	89 0.8×	34	874
Winfried Alberti Germany	21	413 0.9×	385 1.0×	359 1.1×	497 1.9×	198 1.8×	38	1.6k

Countries citing papers authored by D. Goldstein

Since Specialization

Citations

This map shows the geographic impact of D. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Goldstein more than expected).

Fields of papers citing papers by D. Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Goldstein. The network helps show where D. Goldstein may publish in the future.

Co-authorship network of co-authors of D. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of D. Goldstein. A scholar is included among the top collaborators of D. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Goldstein. D. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suga, Jennifer M., Sachdev Thomas, Thach‐Giao Truong, et al.. (2020). Implementing a genomic oncology program in an integrated health care network with large scale genomic Next Generation Sequencing (NGS) testing of advanced cancers in a community setting.. Journal of Clinical Oncology. 38(15_suppl). e19185–e19185. 2 indexed citations

Movsas, Benjamin, Daniel Hunt, Deborah Watkins Bruner, et al.. (2013). Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828. Practical Radiation Oncology. 4(3). 187–191. 28 indexed citations

Somkin, Carol P., Lynn Ackerson, Gail Husson, et al.. (2013). Effect of Medical Oncologists' Attitudes on Accrual to Clinical Trials in a Community Setting. Journal of Oncology Practice. 9(6). e275–e283. 33 indexed citations

Ngan, Samuel Y., R. Fisher, D. Goldstein, et al.. (2010). A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS).. Journal of Clinical Oncology. 28(15_suppl). 3509–3509. 42 indexed citations

Fehrenbacher, L., Howard West, Primo N. Lara, et al.. (2009). Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer. Journal of Clinical Oncology. 27(9). 1401–1404. 34 indexed citations

Park, Sung Soo, Arun V. Krishnan, Cindy Lin, et al.. (2008). Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies. Current Medicinal Chemistry. 15(29). 3081–3094. 159 indexed citations

Schillaci, Orazio, Gerald L. DeNardo, Sally J. DeNardo, et al.. (2007). Effect of Antilymphoma Antibody, ¹³¹ I-Lym-1, on Peripheral Blood Lymphocytes in Patients with Non-Hodgkin's Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 22(4). 521–530. 1 indexed citations

Azinovic, Ignacio, Gerald L. DeNardo, Kathleen R. Lamborn, et al.. (2006). Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies. Cancer Immunology Immunotherapy. 55(12). 1451–1458. 33 indexed citations

Goldstein, D., Guy van Hazel, Nick Pavlakis, & Ian Olver. (2005). Selective Internal Radiation Therapy (SIRT) plus systemic chemotherapy with Irinotecan. A phase I dose escalation study. Journal of Clinical Oncology. 23(16_suppl). 3701–3701. 18 indexed citations

10.

DeNardo, Gerald L., Aina Yuan, D. Goldstein, et al.. (2003). Impact of Interpatient Pharmacokinetic Variability on Design Considerations for Therapy with Radiolabeled MAbs. Cancer Biotherapy and Radiopharmaceuticals. 18(2). 231–237. 6 indexed citations

11.

DeNardo, Gerald L., Sally J. DeNardo, Robert T. OʼDonnell, et al.. (2000). Are Radiometal-Labeled Antibodies Better Than Iodine-131–Labeled Antibodies: Comparative Pharmacokinetics and Dosimetry of Copper-67–, Iodine-131–, and Yttrium-90–Labeled Lym-1 Antibody in Patients with Non-Hodgkin's Lymphoma. Clinical Lymphoma. 1(2). 118–126. 31 indexed citations

12.

OʼDonnell, Robert T., Gerald L. DeNardo, David L. Kukis, et al.. (1999). A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.. PubMed. 40(12). 2014–20. 61 indexed citations

13.

DeNardo, Gerald L., Robert T. OʼDonnell, Linda A. Kroger, et al.. (1999). Strategies for developing effective radioimmunotherapy for solid tumors.. PubMed. 5(10 Suppl). 3219s–3223s. 21 indexed citations

14.

DeNardo, Gerald L., Sally J. DeNardo, Kathleen R. Lamborn, et al.. (1998). Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using ¹³¹ I-LYM-1 Antibody. Cancer Biotherapy and Radiopharmaceuticals. 13(4). 239–254. 78 indexed citations

15.

DeNardo, Gerald L., Sally J. DeNardo, David L. Kukis, et al.. (1998). Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.. PubMed. 18(4B). 2779–88. 53 indexed citations

16.

DeNardo, Gerald L., Kathleen R. Lamborn, D. Goldstein, Linda A. Kroger, & Sally J. DeNardo. (1997). Increased survival associated with radiolabeled lym-1 therapy for non-hodgkin's lymphoma and chronic lymphocytic leukemia. Cancer. 80(S12). 2706–2711. 56 indexed citations

17.

Goldstein, D., et al.. (1997). P.1.048 Effects of first-trimester fluoxetine exposure on the newborn. European Neuropsychopharmacology. 7. S150–S150. 1 indexed citations

18.

Lamborn, Kathleen R., Gerald L. DeNardo, Sally J. DeNardo, et al.. (1997). Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies.. PubMed. 3(8). 1253–60. 20 indexed citations

19.

Goldstein, D., Samuel T. Milliken, Craig Lewis, et al.. (1996). Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma. Annals of Oncology. 7(10). 1029–1036. 7 indexed citations

20.

Pliskin, Neil H., D. Goldstein, Vernon L. Towle, et al.. (1996). Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology. 47(6). 1463–1468. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact